163 related articles for article (PubMed ID: 27825143)
1. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
[TBL] [Abstract][Full Text] [Related]
3. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
4. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13.
Zeng B; Zhu D; Su Z; Li Z; Yu Z
Int Immunopharmacol; 2016 Oct; 39():63-70. PubMed ID: 27424080
[TBL] [Abstract][Full Text] [Related]
7. Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.
Rounbehler RJ; Berglund AE; Gerke T; Takhar MM; Awasthi S; Li W; Davicioni E; Erho NG; Ross AE; Schaeffer EM; Klein EA; Karnes RJ; Jenkins RB; Cleveland JL; Park JY; Yamoah K
Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1376-1383. PubMed ID: 30108099
[No Abstract] [Full Text] [Related]
8. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
[TBL] [Abstract][Full Text] [Related]
9. Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin.
Lee HH; Vo MT; Kim HJ; Lee UH; Kim CW; Kim HK; Ko MS; Lee WH; Cha SJ; Min YJ; Choi DH; Suh HS; Lee BJ; Park JW; Cho WJ
J Biol Chem; 2010 Jun; 285(23):17329-37. PubMed ID: 20335167
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.
Lee JY; Kim HJ; Yoon NA; Lee WH; Min YJ; Ko BK; Lee BJ; Lee A; Cha HJ; Cho WJ; Park JW
Nucleic Acids Res; 2013 Jun; 41(11):5614-25. PubMed ID: 23595149
[TBL] [Abstract][Full Text] [Related]
12. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer.
Lee HH; Son YJ; Lee WH; Park YW; Chae SW; Cho WJ; Kim YM; Choi HJ; Choi DH; Jung SW; Min YJ; Park SE; Lee BJ; Cha HJ; Park JW
Int J Cancer; 2010 Apr; 126(8):1817-1827. PubMed ID: 19697322
[TBL] [Abstract][Full Text] [Related]
14. The role of RNA-binding protein tristetraprolin in cancer and immunity.
Guo J; Qu H; Chen Y; Xia J
Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
[TBL] [Abstract][Full Text] [Related]
15. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1.
Lee HH; Lee SR; Leem SH
J Microbiol Biotechnol; 2014 Feb; 24(2):287-94. PubMed ID: 24150491
[TBL] [Abstract][Full Text] [Related]
16. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
17. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
[TBL] [Abstract][Full Text] [Related]
18. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.
Wei ZR; Liang C; Feng D; Cheng YJ; Wang WM; Yang DJ; Wang YX; Cai QP
Oncotarget; 2016 Apr; 7(14):17737-50. PubMed ID: 26894969
[TBL] [Abstract][Full Text] [Related]
19. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract][Full Text] [Related]
20. Roles of Tristetraprolin in Tumorigenesis.
Park JM; Lee TH; Kang TH
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
